Annual EBITDA:
-$331.45M-$179.89M(-118.70%)Summary
- As of today, INBX annual EBITDA is -$331.45 million, with the most recent change of -$179.89 million (-118.70%) on December 31, 2024.
- During the last 3 years, INBX annual EBITDA has fallen by -$256.09 million (-339.85%).
- INBX annual EBITDA is now -1616.90% below its all-time high of -$19.30 million, reached on December 31, 2017.
Performance
INBX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$33.23M-$6.50M(-24.33%)Summary
- As of today, INBX quarterly EBITDA is -$33.23 million, with the most recent change of -$6.50 million (-24.33%) on September 30, 2025.
- Over the past year, INBX quarterly EBITDA has increased by +$12.81 million (+27.82%).
- INBX quarterly EBITDA is now -1071.72% below its all-time high of -$2.84 million, reached on March 31, 2019.
Performance
INBX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$151.42M+$12.81M(+7.80%)Summary
- As of today, INBX TTM EBITDA is -$151.42 million, with the most recent change of +$12.81 million (+7.80%) on September 30, 2025.
- Over the past year, INBX TTM EBITDA has increased by +$128.50 million (+45.91%).
- INBX TTM EBITDA is now -1636.89% below its all-time high of -$8.72 million, reached on March 31, 2018.
Performance
INBX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INBX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -118.7% | +27.8% | +45.9% |
| 3Y3 Years | -339.9% | -12.8% | -35.9% |
| 5Y5 Years | -659.9% | -116.7% | -149.4% |
INBX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -339.9% | at low | -24.3% | +79.3% | -35.9% | +54.0% |
| 5Y | 5-Year | -659.9% | at low | -116.7% | +79.3% | -149.4% | +54.0% |
| All-Time | All-Time | -1616.9% | at low | -1071.7% | +79.3% | -1636.9% | +54.0% |
INBX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | -$33.23M(-24.3%) | -$151.42M(+7.8%) |
| Jun 2025 | - | -$26.73M(+36.7%) | -$164.23M(+44.9%) |
| Mar 2025 | - | -$42.23M(+14.2%) | -$297.93M(+9.5%) |
| Dec 2024 | -$331.45M(-118.7%) | -$49.24M(-7.0%) | -$329.16M(-17.6%) |
| Sep 2024 | - | -$46.04M(+71.3%) | -$279.93M(-19.7%) |
| Jun 2024 | - | -$160.42M(-118.4%) | -$233.89M(-104.3%) |
| Mar 2024 | - | -$73.47M(-79.0%) | -$114.51M(+22.4%) |
| Dec 2023 | -$151.56M(-32.8%) | - | - |
| Jun 2023 | - | -$41.04M(+5.6%) | -$147.48M(-4.9%) |
| Mar 2023 | - | -$43.47M(-29.8%) | -$140.66M(-11.8%) |
| Dec 2022 | -$114.10M(-51.4%) | -$33.50M(-13.7%) | -$125.86M(-12.9%) |
| Sep 2022 | - | -$29.47M(+13.9%) | -$111.46M(-10.9%) |
| Jun 2022 | - | -$34.22M(-19.3%) | -$100.50M(-17.2%) |
| Mar 2022 | - | -$28.67M(-50.1%) | -$85.78M(-13.8%) |
| Dec 2021 | -$75.36M | -$19.10M(-3.2%) | -$75.36M(-3.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$18.50M(+5.1%) | -$73.10M(-4.5%) |
| Jun 2021 | - | -$19.50M(-6.8%) | -$69.93M(-8.1%) |
| Mar 2021 | - | -$18.25M(-8.3%) | -$64.66M(-1.4%) |
| Dec 2020 | -$63.80M(-46.3%) | -$16.85M(-9.9%) | -$63.80M(-5.1%) |
| Sep 2020 | - | -$15.33M(-7.7%) | -$60.71M(+1.2%) |
| Jun 2020 | - | -$14.23M(+18.1%) | -$61.44M(-6.3%) |
| Mar 2020 | - | -$17.39M(-26.4%) | -$57.81M(-33.6%) |
| Dec 2019 | -$43.62M(-51.6%) | -$13.76M(+14.4%) | -$43.26M(-46.6%) |
| Sep 2019 | - | -$16.07M(-51.7%) | -$29.50M(-119.6%) |
| Jun 2019 | - | -$10.60M(-273.7%) | -$13.43M(-43.9%) |
| Mar 2019 | - | -$2.84M(+56.3%) | -$9.33M(+38.7%) |
| Dec 2018 | -$28.77M(-49.0%) | - | - |
| Jun 2018 | - | -$6.50M(+25.5%) | -$15.21M(-74.5%) |
| Mar 2018 | - | -$8.72M | -$8.72M |
| Dec 2017 | -$19.30M | - | - |
FAQ
- What is Inhibrx Biosciences, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. annual EBITDA year-on-year change?
- What is Inhibrx Biosciences, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Inhibrx Biosciences, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Inhibrx Biosciences, Inc.?
- What is Inhibrx Biosciences, Inc. TTM EBITDA year-on-year change?
What is Inhibrx Biosciences, Inc. annual EBITDA?
The current annual EBITDA of INBX is -$331.45M
What is the all-time high annual EBITDA for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high annual EBITDA is -$19.30M
What is Inhibrx Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, INBX annual EBITDA has changed by -$179.89M (-118.70%)
What is Inhibrx Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of INBX is -$33.23M
What is the all-time high quarterly EBITDA for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high quarterly EBITDA is -$2.84M
What is Inhibrx Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, INBX quarterly EBITDA has changed by +$12.81M (+27.82%)
What is Inhibrx Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of INBX is -$151.42M
What is the all-time high TTM EBITDA for Inhibrx Biosciences, Inc.?
Inhibrx Biosciences, Inc. all-time high TTM EBITDA is -$8.72M
What is Inhibrx Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, INBX TTM EBITDA has changed by +$128.50M (+45.91%)